Authors: | Tse, A.; Yazji, S.; Naing, A.; Matthews, D.; Schwartz, G.; Lawhorn, K.; Kurzrock, R. |
Abstract Title: | Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies |
Meeting Title: | 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
Journal Title: | EJC Supplements |
Volume: | 6 |
Issue: | 12 |
Meeting Dates: | 2008 Oct 21-24 |
Meeting Location: | Geneva, Switzerland |
ISSN: | 1359-6349 |
Publisher: | Pergamon-Elsevier Science Ltd |
Date Published: | 2008-10-01 |
Start Page: | 124 |
Language: | English |
ACCESSION: | WOS:000261221200394 |
DOI: | 10.1016/s1359-6349(08)72329-2 |
PROVIDER: | wos |
Notes: | --- - Meeting Abstract: 395 - Poster - 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - OCT 21-24, 2008 - Geneva, SWITZERLAND - "Source: Wos" |